Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
2011 · Nature · 2,712 citations
https://doi.org/10.1038/nature10251
J
Jeannette Lechner‐Scott
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
495
Papers
19.4K
Citations
58
h-index
199
i10-index
Jeannette Lechner‐Scott is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Polyomavirus and related diseases. The author has an h-index of 58, co-authored 421 publications.
ORCID: 0000-0002-3850-447XPapers by this author
worksAnalysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
2013 · Nature Genetics · 1,430 citations
https://doi.org/10.1038/ng.2770
Locus for severity implicates CNS resilience in progression of multiple sclerosis
2023 · Nature · 206 citations
https://doi.org/10.1038/s41586-023-06250-x
Epigenome-wide association studies: current knowledge, strategies and recommendations
2021 · Clinical Epigenetics · 202 citations
https://doi.org/10.1186/s13148-021-01200-8
Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis
2013 · PLoS ONE · 129 citations
https://doi.org/10.1371/journal.pone.0063480
A deep catalogue of protein-coding variation in 983,578 individuals
2024 · Nature · 93 citations
https://doi.org/10.1038/s41586-024-07556-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat